GB Meka
Stocks to watch

GMED

Compare

GLOBUS MEDICAL INC - A · Healthcare

$74.96
▼ 1.0%Close 2026-09-30

Live intraday price

Compare with our price levels

T281.76
T179.59
E173.00
E369.40
SL67.77

Close 2026-09-30: $74.96 · Levels are calculated once a day from the closing price; live prices come from TradingView (may be delayed at times)

Waiting• Neutral

Not in the buy zone yet — needs to drop 2.6% · 2 whales recently bought

1 month
▼ 7.9%
3 months
▼ 1.3%
1 year
▲ 32.9%
Analyst target
$103.23 +37.7%

🎯 Trade plan by price level

Buy in 3 tranches in the buy zone · sell in 3 tranches at the targets · sell everything if the stop-loss breaks

Price levels and picks are calculated automatically with the same formula for every stock — for education only, not a recommendation to buy or sell. · How it's calculated

Buy zone
E1$73.00 -2.6%
E2$71.85 -4.1%
E3$69.40 -7.4%
Targets
T1$79.59 6.2%
T2$81.76 9.1%
T3$83.17 11.0%
Stop-loss
SL$67.77 -9.6%
Whale cost ~$71.85 -4.1%

Risk : reward 1 : 2.8Moves ~$1.63 a day

⚖️ Positives and risks

✓ Positives (3)
  • ●เซียนซื้อใหม่/ซื้อเพิ่มไตรมาสล่าสุด 2 ราย
  • ●ราคาเป้าหมายนักวิเคราะห์เฉลี่ย 103.23 (upside +38%, 13 ราย)
  • ●นักวิเคราะห์ส่วนใหญ่แนะนำ Buy
! Risks (4)
  • ●เซียนขายออก/ลดสัดส่วน 1 ราย: Lee Ainslie (ขายหมด)
  • ●แนวโน้มระยะยาวเป็นขาลง (ใต้ MA200 และ MA200 ชี้ลง)
  • ●อ่อนแอกว่าตลาด (S&P 500) -32% ใน 6 เดือน
  • ●กำไรหดตัว -26% เทียบปีก่อน

🕯️ Price chart

Green lines = buy zone E1–E3 · orange = targets T1–T3 · red = stop-loss · arrows = where the paper-trading bot bought/sold

🐋 Whales holding this stock

From each whale's latest quarterly filing

👔 Insider buying & selling

Latest trades from SEC Form 4 filings

All companies
Sell

TOBIN JAMES R · Director

2026-09-15 · 30,000 shares @ $74.58

$2M
Sell

ZARRILLI STEPHEN T · Director

2026-08-18 · 25,000 shares @ $87.04

$2M
Sell

Davidar David D · Director

2026-06-05 · 25,000 shares @ $80.76

$2M
Sell

Huller Kelly · Officer

2026-02-25 · 20,000 shares @ $94.50 · pre-planned sale (10b5-1)

$2M
Sell

Huller Kelly · Officer

2026-02-12 · 10,000 shares @ $87.67 · pre-planned sale (10b5-1)

$876,700
Sell

Kline Kyle · CFO

2026-01-08 · 3,594 shares @ $101.10 · pre-planned sale (10b5-1)

$363,353
Sell

Norwalk Leslie V · Director

2026-01-08 · 2,000 shares @ $101.10 · pre-planned sale (10b5-1)

$202,200
Sell

Norwalk Leslie V · Director

2025-12-12 · 4,000 shares @ $88.85 · pre-planned sale (10b5-1)

$355,400
Sell

Kline Kyle · CFO

2025-12-01 · 18,542 shares @ $90.00 · pre-planned sale (10b5-1)

$2M
Sell

Huller Kelly · Officer

2025-11-25 · 7,500 shares @ $90.00 · pre-planned sale (10b5-1)

$675,000
Sell

Davidar David D · Director

2025-11-12 · 25,000 shares @ $86.00

$2M
Sell

ZARRILLI STEPHEN T · Director

2025-11-11 · 25,000 shares @ $84.29

$2M
Sell

RHOADS ANN D · Director

2025-11-10 · 2,000 shares @ $85.00 · pre-planned sale (10b5-1)

$170,000
Sell

RHOADS ANN D · Director

2025-11-07 · 8,000 shares @ $81.00 · pre-planned sale (10b5-1)

$648,000

📊 Past earnings and price reaction

Actual EPS vs. analyst estimates · the price move on the first trading day after the report and over the next 20 trading days

Post-earnings, all stocks
2026-08-06Beat +22%

Actual EPS $1.34 · est. $1.10 · After close

▲ 1.6%

Day 1

-4.9%

Next 20 days

2026-05-07Beat +22%

Actual EPS $1.12 · est. $0.92 · After close

▼ 8.4%

Day 1

+0.4%

Next 20 days

2026-02-24Beat +11%

Actual EPS $1.28 · est. $1.15 · After close

▲ 4.7%

Day 1

-9.2%

Next 20 days

2025-11-06Beat +51%

Actual EPS $1.18 · est. $0.78 · After close

▲ 35.9%

Day 1

+6.1%

Next 20 days

2025-08-07Beat +15%

Actual EPS $0.86 · est. $0.75 · After close

▲ 8.5%

Day 1

+1.5%

Next 20 days

2025-05-08Miss -9%

Actual EPS $0.68 · est. $0.75 · After close

▼ 23.0%

Day 1

+8.1%

Next 20 days

2025-02-20Beat +12%

Actual EPS $0.84 · est. $0.75 · After close

▼ 4.6%

Day 1

-8.3%

Next 20 days

2024-11-05Beat +28%

Actual EPS $0.83 · est. $0.65 · After close

▲ 9.4%

Day 1

+0.5%

Next 20 days

Listen to the earnings call or read the full report on GMED's investor relations page ↗ · Earnings data from Yahoo Finance

💬 User reviews

Rate and review this stock (sign-in required) — reviews don't affect the system's scores

Loading…

Ratings and comments are each user's own opinion. They don't affect the Smart-Money Score, signals, or price levels and are not investment advice · The average counts each person's latest rating, one vote per person

📰 Latest news

All news

No news yet (we only fetch news for stocks with a signal or a high whale score)

🔬 Deep dive

For those who want the detailed numbers

Fundamentals
Market cap$10.0B
Next earnings2026-11-05
P/E (price to earnings)19.1
Forward P/E (on expected earnings)13.8
Revenue growth (YoY)+5.9%
Earnings growth (YoY)-26.2%
Net profit margin+17.0%
ROE+11.8%
Debt to equity (D/E)2%
Dividend yield-
Analyst targets (high / low)$125.00 / $84.00
Number of analysts13
Trend and technical indicators
Trend short / mid / longDowntrend ↘ · Downtrend ↘ · Downtrend ↘
RSI42
MA50 / MA200$79.57 / $84.75
Distance from MA200-11.6%
MACDPositive
1-year high / low$101.40 / $55.74
vs. S&P 500 (6 months)-31.7%
Volume vs. average0.13×